← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Akina, Inc.
West Lafayette, IN
$2,494,723
Total funding
8
Grants
Funding over time
peak $621.1K · FY2007–23$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,191,331 · 7
FDA$303,392 · 1
By mechanism
R44$1,362,841 · 2
R43$620,001 · 4
U01$303,392 · 1
N43$208,489 · 1
Investigators at Akina, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Delayed Hydrogel Tissue Expander$381,341
R44 · FY2010 · RR
Delayed Hydrogel Tissue Expander$368,659
R44 · FY2009 · RR
Reshapable Hydrogel Tissue Expander$325,813
R44 · FY2013 · GM
Injectable 3-month buprenorphine PLGA microparticle formulation$320,000
R43 · FY2023 · DA
Reshapable Hydrogel Tissue Expander$287,028
R44 · FY2014 · GM
Tumor-Microenvironment-on-Chip of Breast Cancer$208,489
N43 · FY2014 · CA
Development of hydrogel-based in vitro dissolution apparatus for microparticle formulations$125,625
U01 · FY2014 · FD
Development of hydrogel-based in vitro dissolution apparatus for microparticle formulations$124,375
U01 · FY2015 · FD
Intra-Oral drug-eluting adhesive film$100,001
R43 · FY2011 · DE
Delayed Hydrogel Tissue Expander$100,000
R43 · FY2007 · RR
Elastic biodegradable ureteral stent$100,000
R43 · FY2009 · DK
Development of hydrogel-based in vitro dissolution apparatus for microparticle formulations$31,094
U01 · FY2015 · FD
Development of hydrogel-based in vitro dissolution apparatus for microparticle formulations$22,298
U01 · FY2016 · FD